Characterization of candidate anti-allergic probiotic strains in a model of Th2-skewed human peripheral blood mononuclear cells

International Archives of Allergy and Immunology

Volumn 161, Issue 2, 2013, Pages 142-154

  Holvoet, Sébastien ^a   Zuercher, Adrian W ^a   Julien Javaux, Françoise ^a   Perrot, Marie ^a   Mercenier, Annick ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Allergy; Anti CD40; Interleukin 4; Peripheral blood mononuclear cells; Probiotics; Th2 cytokines

Indexed keywords

ANTIALLERGIC AGENT; CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7; MESSENGER RNA; PROBIOTIC AGENT; ALLERGEN; OVALBUMIN;

ALLERGY; ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL STRAIN; CLINICAL ASSESSMENT; COCULTURE; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG SCREENING; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; TH2 CELL; VALIDATION PROCESS; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MOUSE; NORMAL HUMAN; SCREENING TEST; SUPERNATANT;

ADOLESCENT; ADULT; ANIMALS; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED BALB C; PRINCIPAL COMPONENT ANALYSIS; PROBIOTICS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH2 CELLS; YOUNG ADULT;

EID: 84872795457     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000343703     Document Type: Article

References (40)

1. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351: 1225-1232.
2. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001; 357: 1076-1079.
3. Kukkonen K, Savilahti E, Haahtela T, et al: Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebocontrolled trial. J Allergy Clin Immunol 2007; 119: 192-198.
4. Abrahamsson TR, Jakobsson T, Bottcher MF, et al: Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1174-1180.
5. Kim JY, Kwon JH, Ahn SH, et al: Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010; 21:e386-e393.
6. Niers L, Martin R, Rijkers G, et al: The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009; 64: 1349-1358.
7. Taylor AL, Dunstan JA, Prescott SL: Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. J Allergy Clin Immunol 2007; 119: 184-191.
8. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R: Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: No clinical effects of Lactobacillus GG supplementation. Pediatrics 2008; 121:e850-e856.
9. Soh SE, Aw M, Gerez I, et al: Probiotic supplementation in the first 6 months of life in at risk Asian infants Y effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009; 39: 571-578.
10. Lee J, Seto D, Bielory L: Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008; 121: 116-121.
11. Viljanen M, Savilahti E, Haahtela T, et al: Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: A doubleblind placebo-controlled trial. Allergy 2005; 60: 494-500.
12. Weston S, Halbert A, Richmond P, Prescott SL: Effects of probiotics on atopic dermatitis: A randomised controlled trial. Arch Dis Child 2005; 90: 892-897.
13. Boyle RJ, Tang ML: The role of probiotics in the management of allergic disease. Clin Exp Allergy 2006; 36: 568-576.
14. Gerasimov SV, Vasjuta VV, Myhovych OO, Bondarchuk LI: Probiotic supplement reduces atopic dermatitis in preschool children: A randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol 2010; 11: 351-361.
15. Xiao JZ, Kondo S, Yanagisawa N, et al: Probiotics in the treatment of Japanese cedar pollinosis: A double-blind placebo-controlled trial. Clin Exp Allergy 2006; 36: 1425-1435.
16. Peng GC, Hsu CH: The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Immunol 2005; 16: 433-438.
17. Chen YS, Jan RL, Lin YL, Chen HH, Wang JY: Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol 2010; 45: 1111-1120.
18. Penders J, Stobberingh EE, van den Brandt PA, Thijs C: The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007; 62: 1223-1236.
19. Prescott SL, Bjorksten B: Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 2007; 120: 255-262.
20. Kekkonen RA, Kajasto E, Miettinen M, Veckman V, Korpela R, Julkunen I: Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production. World J Gastroenterol 2008; 14: 1192-1203.
21. Niers LE, Timmerman HM, Rijkers GT, et al: Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 2005; 35: 1481-1489.
22. Mohamadzadeh M, Olson S, Kalina WV, et al: Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA 2005; 102: 2880-2885.
23. Foligne B, Nutten S, Grangette C, et al: Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 2007; 13: 236-243.
24. Fujiwara D, Inoue S, Wakabayashi H, Fujii T: The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol 2004; 135: 205-215.
25. Fujiwara D, Wakabayashi H, Watanabe H, Nishida S, Iino H: A double-blind trial of Lactobacillus paracasei strain KW3110 administration for immunregulation in patients with pollen allergy. Allergol Int 2005; 54: 143-149.
26. Vissers YM, Snel J, Zuurendonk PF, Kleerebezem M, Wichers HJ, Savelkoul HF: Lactobacillus strains differentially modulate cytokine production by hPBMC from pollenallergic patients. FEMS Immunol Med Microbiol 2011; 61: 28-40.
27. Rousset F, Garcia E, Banchereau J: Cytokineinduced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 1991; 173: 705-710.
28. Yao Y, Li W, Kaplan MH, Chang CH: Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med 2005; 201: 1899-1903.
29. Dunstan JA, Hale J, Breckler L, et al: Atopic dermatitis in young children is associated with impaired interleukin-10 and interferon-gamma responses to allergens, vaccines and colonizing skin and gut bacteria. Clin Exp Allergy 2005; 35: 1309-1317.
30. Roessler A, Friedrich U, Vogelsang H, et al: The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clin Exp Allergy 2008; 38: 93-102.
31. Prioult G, Nagler-Anderson C: Mucosal immunity and allergic responses: Lack of regulation and/or lack of microbial stimulation? Immunol Rev 2005; 206: 204-218.
32. Smits HH, Engering A, van der KD, et al: Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005; 115: 1260-1267.
33. Prescott SL, Wickens K, Westcott L, et al: Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferongamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clin Exp Allergy 2008; 38: 1606-1614.
34. Viljanen M, Pohjavuori E, Haahtela T, et al: Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol 2005; 115: 1254-1259.
35. Marschan E, Kuitunen M, Kukkonen K, et al: Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008; 38: 611-618.
36. Prescott SL, Dunstan JA, Hale J, et al: Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin Exp Allergy 2005; 35: 1557-1564.
37. Snel J, Vissers YM, Smit BA, et al: Strain-specific immunomodulatory effects of Lactobacillus plantarum strains on birch-pollen-allergic subjects out of season. Clin Exp Allergy 2011; 41: 232-242.
38. van Wijk F, Wehrens EJ, Nierkens S, et al: CD4+CD25+ T cells regulate the intensity of hypersensitivity responses to peanut, but are not decisive in the induction of oral sensitization. Clin Exp Allergy 2007; 37: 572-581.
39. Wassenberg J, Nutten S, Audran R, et al: Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. Clin Exp Allergy 2011; 41: 565-573.
40. Lodinová-Zádníková R, Cukrowska B, Tlaskalova-Hogenova H: Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 2003; 131: 209-211.